Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer. | Tumori;101(4): 404-11, 2015. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer.

Shen, Hong; Feng, Ganzhu; Cui, Jin; Du, Qiang; Qin, Yong; Cai, Jiankang; Shen, Li; Zhu, Yina.

Affiliation

Shen H; Department of Respiratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing - China.

Tumori ; 101(4): 404-11, 2015.

Article in En | MEDLINE | ID: mdl-25983091

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Effusion / Vascular Endothelial Growth Factor A / Hypoxia-Inducible Factor 1, alpha Subunit / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Tumori Year: 2015 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Effusion / Vascular Endothelial Growth Factor A / Hypoxia-Inducible Factor 1, alpha Subunit / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Tumori Year: 2015 Document type: Article Country of publication: